Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University Hospital, posted on X:
“How have CDK4/6i impacted the OS in first-line for HR+/HER2- advanced breast cancer? Delighted to share this editorial in Annals of Oncology, coauthored with Mafalda Oliveira.”
Source: Rodrigo Sánchez-Bayona/X